SillaJen, Inc. (215600.KQ)

KRW 2565.0

(0.79%)

Long Term Debt Summary of SillaJen, Inc.

SillaJen, Inc.'s latest annual long term debt in 2023 was 8.13 Billion KRW , up 19.24% from previous year.
SillaJen, Inc.'s latest quarterly long term debt in 2024 Q2 was 714.03 Million KRW , down -100.0% from previous quarter.
SillaJen, Inc. reported annual long term debt of 6.82 Billion KRW in 2022, up 19.24% from previous year.
SillaJen, Inc. reported annual long term debt of 5.72 Billion KRW in 2021, down -56.27% from previous year.
SillaJen, Inc. reported quarterly long term debt of 8.5 Billion KRW for 2024 Q1, up 4.48% from previous quarter.
SillaJen, Inc. reported quarterly long term debt of 8.13 Billion KRW for 2023 FY, up 19.24% from previous quarter.

Annual Long Term Debt Chart of SillaJen, Inc. (2023 - 2014)

Historical Annual Long Term Debt of SillaJen, Inc. (2023 - 2014)

Year	Long Term Debt	Long Term Debt Growth
2023	8.13 Billion KRW	19.24%
2022	6.82 Billion KRW	19.24%
2021	5.72 Billion KRW	-56.27%
2020	13.08 Billion KRW	2392.85%
2019	524.95 Million KRW	0.0%
2018	- KRW	0.0%
2017	- KRW	0.0%
2016	- KRW	-100.0%
2015	8.39 Billion KRW	-76.77%
2014	36.13 Billion KRW	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	714.03 Million KRW	-100.0%
2024 Q1	8.5 Billion KRW	4.48%
2023 FY	8.13 Billion KRW	19.24%
2023 Q3	7.78 Billion KRW	4.53%
2023 Q1	7.12 Billion KRW	4.44%
2023 Q4	8.13 Billion KRW	4.53%
2023 Q2	7.44 Billion KRW	4.48%
2022 Q2	6.24 Billion KRW	4.48%
2022 Q4	6.82 Billion KRW	4.53%
2022 FY	6.82 Billion KRW	19.24%
2022 Q3	6.52 Billion KRW	4.53%
2022 Q1	5.97 Billion KRW	4.44%
2021 FY	5.72 Billion KRW	-56.27%
2021 Q2	5.23 Billion KRW	-61.75%
2021 Q3	5.47 Billion KRW	4.53%
2021 Q4	5.72 Billion KRW	4.53%
2021 Q1	13.69 Billion KRW	0.48%
2020 Q4	13.62 Billion KRW	2.27%
2020 FY	13.08 Billion KRW	2392.85%
2020 Q3	13.32 Billion KRW	0.71%
2020 Q2	13.23 Billion KRW	3101.36%
2020 Q1	413.34 Million KRW	-21.26%
2019 FY	524.95 Million KRW	0.0%
2019 Q4	524.95 Million KRW	-99.15%
2019 Q3	61.86 Billion KRW	3.36%
2019 Q2	59.85 Billion KRW	6.96%
2019 Q1	55.96 Billion KRW	0.0%
2018 Q4	- KRW	0.0%
2018 Q2	- KRW	0.0%
2018 Q3	- KRW	0.0%
2018 Q1	- KRW	0.0%
2018 FY	- KRW	0.0%
2017 Q2	- KRW	0.0%
2017 Q1	- KRW	0.0%
2017 Q4	- KRW	0.0%
2017 Q3	- KRW	0.0%
2017 FY	- KRW	0.0%
2016 Q2	38.16 Billion KRW	36.31%
2016 Q4	- KRW	-100.0%
2016 Q3	10 Billion KRW	-73.79%
2016 Q1	28 Billion KRW	233.65%
2016 FY	- KRW	-100.0%
2015 Q1	37.72 Billion KRW	4.39%
2015 Q3	29.52 Billion KRW	-4.93%
2015 Q4	8.39 Billion KRW	-71.57%
2015 Q2	31.05 Billion KRW	-17.68%
2015 FY	8.39 Billion KRW	-76.77%
2014 FY	36.13 Billion KRW	0.0%
2014 Q4	36.13 Billion KRW	0.0%

Peer Long Term Debt Comparison of SillaJen, Inc.

Name	Long Term Debt	Long Term Debt Difference
HLB Co., Ltd.	17.93 Billion KRW	54.633%
iNtRON Biotechnology, Inc.	258.29 Million KRW	-3049.83%
BINEX Co., Ltd.	5.57 Billion KRW	-45.847%
Bioneer Corporation	12.5 Billion KRW	34.913%
Anterogen.Co.,Ltd.	- KRW	-Infinity%
MEDIPOST Co., Ltd.	6.99 Billion KRW	-16.311%
CrystalGenomics, Inc.	29.88 Billion USD	72.78%
Helixmith Co., Ltd	151.68 Million KRW	-5263.825%
Chabiotech Co.,Ltd.	95.06 Billion KRW	91.442%
Medy-Tox Inc.	1.22 Billion KRW	-563.695%
Peptron, Inc.	4.5 Billion KRW	-80.797%
Amicogen, Inc.	70.65 Billion KRW	88.485%
Genexine, Inc.	22.68 Billion KRW	64.13%
HLB Therapeutics Co.,Ltd.	1.84 Billion KRW	-342.12%
LegoChem Biosciences, Inc.	528.37 Million KRW	-1439.794%
ALTEOGEN Inc.	1.24 Billion KRW	-551.255%
PharmaResearch Co., Ltd.	970.71 Million KRW	-738.128%
JETEMA, Co., Ltd.	60 Billion KRW	86.44%
OliX Pharmaceuticals,Inc	35.36 Billion KRW	76.992%
Genomictree Inc.	97.51 Million KRW	-8243.121%
MedPacto, Inc.	1.68 Billion KRW	-382.283%
D&D Pharmatech	5.12 Billion KRW	-58.884%
EASY BIO,Inc.	30 Billion KRW	72.881%
GI Innovation, Inc.	2.9 Billion KRW	-180.159%